Hiroyuki Ebinuma

2.1k total citations
21 papers, 1.0k citations indexed

About

Hiroyuki Ebinuma is a scholar working on Physiology, Epidemiology and Immunology. According to data from OpenAlex, Hiroyuki Ebinuma has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Hiroyuki Ebinuma's work include Adipokines, Inflammation, and Metabolic Diseases (6 papers), Adipose Tissue and Metabolism (4 papers) and Blood properties and coagulation (3 papers). Hiroyuki Ebinuma is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (6 papers), Adipose Tissue and Metabolism (4 papers) and Blood properties and coagulation (3 papers). Hiroyuki Ebinuma collaborates with scholars based in Japan, Austria and United Kingdom. Hiroyuki Ebinuma's co-authors include Kazuo Hara, Toshimasa Yamauchi, Takashi Kadowaki, Osamu Miyazaki, Hirokazu Yago, Ryozo Nagai, Yasushi Imai, Momoko Horikoshi, Yusuke Hada and Hideaki Bujo and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Hiroyuki Ebinuma

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Ebinuma Japan 11 699 488 227 173 166 21 1.0k
Naoto Kubota Japan 6 788 1.1× 529 1.1× 238 1.0× 267 1.5× 323 1.9× 14 1.2k
Jack C.‐R. Tsai Taiwan 9 701 1.0× 392 0.8× 299 1.3× 220 1.3× 168 1.0× 12 1.2k
Izumi Hashimoto Japan 14 415 0.6× 370 0.8× 153 0.7× 202 1.2× 300 1.8× 23 1.1k
Carolin Tonus Germany 9 764 1.1× 537 1.1× 238 1.0× 165 1.0× 214 1.3× 25 1.3k
永井 良三 Japan 2 787 1.1× 548 1.1× 260 1.1× 269 1.6× 225 1.4× 2 1.2k
Matthew C. Ernst Canada 8 652 0.9× 471 1.0× 180 0.8× 177 1.0× 216 1.3× 9 1.1k
P Sucharda Czechia 6 427 0.6× 338 0.7× 149 0.7× 209 1.2× 145 0.9× 19 869
Monique Verdier France 13 552 0.8× 324 0.7× 124 0.5× 67 0.4× 255 1.5× 17 1.0k
Momoko Horikoshi Japan 17 565 0.8× 368 0.8× 214 0.9× 116 0.7× 494 3.0× 25 1.5k
Daniela Friebe Germany 14 323 0.5× 365 0.7× 137 0.6× 94 0.5× 256 1.5× 20 893

Countries citing papers authored by Hiroyuki Ebinuma

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Ebinuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Ebinuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Ebinuma more than expected).

Fields of papers citing papers by Hiroyuki Ebinuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Ebinuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Ebinuma. The network helps show where Hiroyuki Ebinuma may publish in the future.

Co-authorship network of co-authors of Hiroyuki Ebinuma

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Ebinuma. A scholar is included among the top collaborators of Hiroyuki Ebinuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Ebinuma. Hiroyuki Ebinuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimizu, Naomi, et al.. (2024). Diagnostic Value of sLR11 and sIL-2R in the Cerebrospinal Fluid for Malignant Central Nervous System Lymphoma. Internal Medicine. 63(20). 2767–2771.
2.
Shimizu, Naomi, et al.. (2023). The Potential Utility of Cerebral Fluid sLR11 and sIL-2R As a Marker for CNS Involvement of Malignant Lymphoma. Blood. 142(Supplement 1). 6128–6128. 1 indexed citations
3.
Joki, Yusuke, et al.. (2021). Circulating sLR11 levels predict severity of pulmonary hypertension due to left heart disease. PLoS ONE. 16(12). e0261753–e0261753. 1 indexed citations
4.
Ishida, Hiroaki, Meizi Jiang, Hiroyuki Ebinuma, et al.. (2019). Circulating soluble LR11, a differentiation regulator for vascular cells, is increased during pregnancy and exaggerated in patients with pre-eclampsia. Clinica Chimica Acta. 497. 172–177. 3 indexed citations
5.
Hirayama, Satoshi, Tsuyoshi Ueno, Yumiko Motoi, et al.. (2018). Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid–high-density lipoprotein. Clinica Chimica Acta. 489. 29–34. 1 indexed citations
6.
Jiang, Meizi, Wataru Tokuyama, Takeyoshi Murano, et al.. (2016). Levels of soluble LR11/SorLA are highly increased in the bile of patients with biliary tract and pancreatic cancers. Clinica Chimica Acta. 457. 130–136. 16 indexed citations
7.
Jiang, Meizi, Takeyoshi Murano, Nobuyuki Hiruta, et al.. (2016). Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes. Clinica Chimica Acta. 457. 137–141. 7 indexed citations
8.
Jiang, Le, Hakuoh Konishi, Fariz Nurwidya, et al.. (2016). Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 36(9). 1972–1979. 8 indexed citations
9.
Whittle, Andrew J., Meizi Jiang, Vivian Peirce, et al.. (2015). Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nature Communications. 6(1). 8951–8951. 55 indexed citations
10.
Vongpromek, Ranitha, Hideaki Bujo, Menno Hoekstra, et al.. (2015). LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients. Atherosclerosis. 243(2). 429–437. 6 indexed citations
11.
Ebinuma, Hiroyuki, Isamu Fukamachi, Chikako Ohwada, et al.. (2014). Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma. Clinica Chimica Acta. 430. 48–54. 9 indexed citations
12.
Nakaseko, Chiaki, Masahiro Takeuchi, Chikako Ohwada, et al.. (2012). Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias. Clinica Chimica Acta. 413(19-20). 1542–1548. 15 indexed citations
13.
Ikeuchi, Takeshi, Satoshi Hirayama, Takashi Miida, et al.. (2010). Increased Levels of Soluble LR11 in Cerebrospinal Fluid of Patients with Alzheimer Disease. Dementia and Geriatric Cognitive Disorders. 30(1). 28–32. 31 indexed citations
14.
Ebinuma, Hiroyuki, et al.. (2009). Development of an Immunoassay for the Quantification of Soluble LR11, a Circulating Marker of Atherosclerosis. Clinical Chemistry. 55(10). 1801–1808. 30 indexed citations
15.
Hada, Yusuke, Toshimasa Yamauchi, Hironori Waki, et al.. (2007). Selective purification and characterization of adiponectin multimer species from human plasma. Biochemical and Biophysical Research Communications. 356(2). 487–493. 127 indexed citations
16.
Ebinuma, Hiroyuki, Takashi Miida, Toshimasa Yamauchi, et al.. (2007). Improved ELISA for Selective Measurement of Adiponectin Multimers and Identification of Adiponectin in Human Cerebrospinal Fluid. Clinical Chemistry. 53(8). 1541–1544. 63 indexed citations
17.
18.
Ebinuma, Hiroyuki, Osamu Miyazaki, Hirokazu Yago, et al.. (2006). A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clinica Chimica Acta. 372(1-2). 47–53. 136 indexed citations
19.
Hara, Kazuo, Momoko Horikoshi, Toshimasa Yamauchi, et al.. (2006). Measurement of the High–Molecular Weight Form of Adiponectin in Plasma Is Useful for the Prediction of Insulin Resistance and Metabolic Syndrome. Diabetes Care. 29(6). 1357–1362. 478 indexed citations
20.
Sone, Hirohito, Hitoshi Shimano, Hiroyuki Ebinuma, et al.. (2003). Physiological changes in circulating mannose levels in normal, glucose-intolerant, and diabetic subjects. Metabolism. 52(8). 1019–1027. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoto Kubota Breakdown of academic impact, for papers by Jack C.‐R. Tsai Breakdown of academic impact, for papers by Izumi Hashimoto Breakdown of academic impact, for papers by Carolin Tonus Breakdown of academic impact, for papers by 永井 良三 Breakdown of academic impact, for papers by Matthew C. Ernst Breakdown of academic impact, for papers by P Sucharda Breakdown of academic impact, for papers by Monique Verdier Breakdown of academic impact, for papers by Momoko Horikoshi Breakdown of academic impact, for papers by Daniela Friebe
Rankless by CCL
2026